Core Technology and Philosophy

At the heart of Biochemize S.L. is the mastery of biocatalysis. The company operates on the principle that biological catalysts offer superior selectivity compared to traditional metal-based catalysts. This includes chemo-, regio-, and enantioselectivity, which are critical for the production of chiral drugs and complex intermediates. Biochemize emphasizes a "Process-First" approach, where the enzyme is not just a reagent but a tool integrated into a holistically optimized industrial workflow. This philosophy addresses the common bottlenecks in biotechnologyâ??namely enzyme stability, cost of production, and industrial scalability. By applying biological solutions to chemical problems, they contribute to the circular economy and reduce the carbon intensity of manufacturing.

Product Portfolio

Biochemize S.L. offers a diverse range of products categorized under proprietary enzymes and specialized chemical intermediates produced via biological routes.

1. Enzyme Libraries and Biocatalysts

The company maintains an extensive collection of enzymes designed for specific chemical transformations. These are available for screening and bulk purchase: * Hydrolases (Lipases, Proteases, Esterases): These are utilized extensively for the resolution of racemic mixtures and the production of enantiopure alcohols, amines, and carboxylic acids through hydrolysis or transesterification. * Oxidoreductases (Ketoreductases, Alcohol Dehydrogenases): These enzymes are critical for the asymmetric reduction of ketones to chiral alcohols, a foundational step in the synthesis of many blockbuster drugs. * Transferases and Lyases: Used for more complex bond-forming reactions, such as C-C bond formation or the addition of small molecules across double bonds, which are traditionally difficult to achieve with high stereocontrol. * Specialty Enzymes: Including nitrilases and transaminases for the production of non-natural amino acids and specialized aminated compounds.

2. Bio-based Intermediates and Building Blocks

Beyond the catalysts themselves, Biochemize provides high-purity chemical intermediates. These are often "difficult-to-synthesize" molecules where biocatalysis provides a distinct competitive advantage in terms of cost and purity. These products cater primarily to the Active Pharmaceutical Ingredient (API) sector, offering enantiopure building blocks that reduce the number of steps in drug synthesis.

Comprehensive Service Offerings

Biochemize S.L. functions as a high-end Contract Research Organization (CRO) and process development partner. Their service pipeline is designed to take a project from the conceptual "paper chemistry" stage to full industrial implementation.

1. Biocatalytic Screening and Feasibility Studies

For clients looking to improve an existing chemical route or develop a new one, Biochemize performs rapid screening of its internal enzyme libraries. This service identifies the most efficient biocatalyst for a specific substrate, providing data on conversion rates, selectivity, and potential yields. This initial phase ensures that the biological route is economically viable before further investment is made.

2. Enzyme Engineering and Optimization

Recognizing that "wild-type" enzymes often lack the robustness required for harsh industrial conditions, Biochemize employs protein engineering techniques. This includes directed evolution and rational design to enhance enzyme stability against temperature, pH, and organic solvents, as well as increasing the catalyst's turnover frequency (TOF). This customization ensures the enzyme performs optimally within the client's specific manufacturing parameters.

3. Bioprocess Development and Scale-up

One of the companyâ??s strongest value propositions is its ability to scale processes from the lab bench to the factory floor. This service includes: * Reaction Engineering: Optimizing substrate loading, buffer systems, and cofactor regeneration cycles. In reactions involving oxidoreductases, the cost of nicotinamide cofactors (NADH/NADPH) is minimized through integrated enzymatic regeneration systems. * Downstream Processing (DSP): Developing efficient methods to isolate the target product from the aqueous reaction media. This includes specialized extraction, filtration, and crystallization techniques that maintain the high purity achieved during the enzymatic step. * Enzyme Immobilization: To further lower costs, Biochemize develops immobilized enzyme preparations. By attaching the catalyst to a solid support, the enzyme can be recovered and reused for multiple reaction cycles, significantly decreasing the "enzyme cost per kg" of product. * Tech Transfer: Providing the necessary documentation and technical support to transition the process to the client's facility or a third-party manufacturer.

4. Custom Synthesis

Biochemize provides custom synthesis services for molecules that require a high degree of structural complexity. By combining traditional organic synthesis with targeted biocatalytic steps (chemo-enzymatic synthesis), they produce molecules that are otherwise inaccessible or prohibitively expensive via 100% chemical means.

Strategic Market Impact

The impact of Biochemize S.L. spans several high-growth sectors within the life sciences: * Pharmaceuticals: Facilitating the synthesis of chiral intermediates for antivirals, antibiotics, and cardiovascular medications, where purity is a regulatory mandate. * Cosmeceuticals: Producing natural and "clean label" ingredients through enzymatic esterification, avoiding the use of heavy metals and reducing the need for harsh solvents. * Fine Chemicals: Developing sustainable routes for high-value flavors, fragrances, and specialty polymers that require precise molecular architectures.

Conclusion

Biochemize S.L. represents the modern evolution of the chemical industry in Spain and the broader European market. By providing both the specialized tools (enzymes) and the engineering expertise (process development), they enable a transition toward a sustainable, bio-based economy. Their role as an intermediary between biological discovery and industrial application makes them an essential partner for companies seeking to meet both ESG (Environmental, Social, and Governance) goals and rigorous economic performance standards in the global life sciences landscape.